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Genomic organization and diversity of Clostridium botulinum 
group III – the bug behind animal botulism 
Abstract 
Botulism is caused by botulinum neurotoxins (BoNTs) produced by the spore forming 
strictly anaerobic bacterium Clostridium botulinum. Seven different types of BoNTs 
(type A-F) have so far been established on the basis of neutralization with different 
antibodies. Botulism affects both humans and animals, and there are occasionally large-
scale outbreaks of high mortality in animals. Especially large outbreaks of avian 
botulism have been reported from various countries, including Sweden. Other animals 
relatively commonly affected are cattle, horses, sheep and farmed fur animals. C. 
botulinum is a diverged species and can be organized into four groups, which reflect 
their genetic and physiological differences. C. botulinum group III strains producing 
BoNT types C, D and chimers C/D and D/C, are mainly connected to animal botulism. 
The gene encoding BoNT in C. botulinum group III strains is located on an unstable 
plasmid-like phage.  
In this thesis, strains of the previously relatively uncharacterised C. botulinum group 
III were isolated and genotyped with pulsed-field gel electrophoresis. Several 
pulsotypes were formed, but the majority clustered closely together and represented 
most of the chimeric strains. Strains representing different pulsotypes and different 
animal and geographical origin, were selected for whole genome sequencing and the 
resulting genomes could be divided into four genomic lineages. Comparisons against 
genomes of Clostridium novyi and Clostridium haemolyticum revealed that they could 
be organized into the same genomic lineages (lineages II-IV), which resulted in the 
suggested collective term C. novyi sensu lato. The organization of all sequenced 
genomes was analysed. It revealed a relatively conserved chromosome and an 
abundance of highly dynamic plasmids. The plasmids, lineages and species were 
entwined because plasmids and toxin genes had moved across the lineage boundaries. 
Of the four lineages, only lineage I was C. botulinum specific, and this lineage includes 
strains of the most common pulsotype. One genome of lineage I was assembled into 
completion. It was smaller than C. botulinum group I and II genomes, but contained as 
much as five plasmids. Most of the identified putative toxin genes were found on these 
plasmids. Strains of lineage I may be more virulent than other C. botulinum group III 
strains, which is reflected by their domination in animal botulism cases today.  
Keywords: Clostridium botulinum, botulinum neurotoxin, BoNT, botulism, PFGE, 
genome, plasmid, bacteriophage, Clostridium novyi, Clostridium haemolyticum.  
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“Fågeldöden kan sprida livsfarlig sjukdom”  
[Transl. Bird deaths can spread deadly disease] 
 
Those words were the heading of an article hanging on the wall in the 
laboratory where I started studying botulism. It was in the midst of the tumult 
caused by the increasing number of avian botulism outbreaks in Sweden. 
Along with the outbreaks there was a flow of samples coming into the 
laboratory for analysis. All day long I cut pieces of chicken caeca, cultivated 
them and analysed them for the presence of Clostridium botulinum. It was a 
tedious job not to mention the very badly smelling working material! However, 
I did not know it at the time, but these foul smelling chicken samples later 
became the foundation of this thesis. The number of reported animal botulism 
outbreaks has increased during the last decade, not only in Sweden, but in 
several European countries (Skarin et al., 2013). As C. botulinum produces an 
extremely toxic neurotoxin, botulism research became a part of an EU project, 
AniBioThreat, which aimed to improve the EU's capacity to counter biological 
animal bio-threats in terms of awareness, prevention and contingency 
(AniBioThreat, 2010). This opened up the possibility for a PhD project about 
botulism. Now after four years of research, this thesis represents the content of 




























2.1 Clostridium botulinum and botulism 
2.1.1 A historical glance 
The first mentioning of botulinum poisoning was in Germany in the 17th 
century, where patients who had eaten blood sausages suffered from paralytic 
symptoms. The word botulism comes from the Latin word for sausage, botulus. 
However, the bacterium itself was not mentioned until 1897 in Belgium, where 
several people became ill and died from eating incompletely salted ham at a 
wake. A professor in Ghent named Èmile van Ermengem examined the ham in 
a microscope and discovered rod-shaped bacteria. He called them Bacillus 
botulinus, having in mind the previous reports from Germany where similar 
symptoms had been described. Van Ermengem established that the illness of 
botulism resulted from an extremely potent toxin that was produced by this 
bacterium (van Ermengem, 1979). In 1917 the genus Bacillus was divided into 
Bacillus for aerobic species and Clostridium for anaerobic species, thus 
Bacillus botulinus was changed into Clostridium botulinum (Winslow et al., 
1917).  
2.1.2 Etiology  
Clostridium botulinum is a Gram-positive, anaerobic, rod-shaped bacterium, 
which occurs as single rods or in short chains (Figure 1). The rods measure 
0.3-1.9 um in width and 1.6-9.4 um in length (Smith and Hobbs, 1974). They 
have flagella and form oval endospores with a varying resistance to heat (from 
very high to low), depending on the strain (Table 2) (Ito et al., 1967, Segner 
and Schmidt, 1971, Peck et al., 2011). These spores are distributed in soil and 
aquatic sediments around the world (Hauschild, 1989, Hatheway, 1990). C. 
botulinum produces extremely potent botulinum neurotoxins (BoNTs), 
probably with the purpose to kill the host by intoxication. It can propagate 
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from nutrients made available by saprophytic organisms and produce spores 
and toxin in the anaerobic environment provided by the dead host, thereby 
ensuring its own spread through larvae or scavenging animals. BoNTs cause 
the disease botulism affecting both humans and animals, although it is more 
common in animals (Critchley, 1991). The mortality is high if treatment with 
antitoxins and respiratory support is not given (WHO, 2013). Animals, which 
are seldom treated, are occasionally victims to large botulism outbreaks. 
 
Figure 1. Scanning electron microscopy image of C. botulinum vegetative cells (Photo: H. Skarin, 
SVA and Leif Ljung, Uppsala University) 
2.1.3 Taxonomy and classification  
C. botulinum is a taxonomic designation for bacteria that produce one or 
more BoNTs (Smith and Hobbs, 1974). In the beginning of the 20th century it 
was noted that different strains of C. botulinum produced toxins that had 
different antigenicities, since antitoxins raised towards one toxin did not 
necessarily neutralize toxins produced by other strains (Leuchs, 1910). These 
antigenetically distinguishable BoNTs were given alphabetical designations 
upon discovery; type A and B (Burke, 1919), C (Bengtson, 1922), D (Meyer 
and Gunnison, 1928), E (Gunnison et al., 1936), F (Möller and Scheibel, 
1960), G (Gimenez and Ciccarelli, 1970) and recently H (Barash and Arnon, 
2014), although the latter is being questioned (Maslanka et al., 2015). The 
BoNTs have a high degree of primary sequence conservation but pair-wise 
comparisons between the seven neurotoxin amino acid sequences (A-G) reveal 
identities of 30.4-62.8% (Hill and Smith, 2013). C. botulinum strains are 
defined upon which BoNT they produce, thus a C. botulinum type A strain 
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produces BoNT/A etc. BoNT/A and B are responsible for the majority of 
human botulism cases whereas BoNT/C and D are associated with disease in 
animals. BoNT/E and F are mainly connected to disease in humans, although 
type E also cause botulism in fish and fish-eating birds (Yule et al., 2006). 
BoNT/G has so far only once been associated with human botulism 
(Sonnabend et al., 1981). The most commonly affected species for each BoNT 
type are presented in Table 1. 
Table 1. Species most commonly affected by botulism and responsible botulinum neurotoxin 
(BoNT) type 
BoNT type Most affected species  
A Humans 
B Humans, cattle, horses 
C  Birds, cattle, sheep, horses, mink 
D Cattle, sheep 
E Humans, fish, birds 
F Humans 
G Humans (rare) 
 
There are also strains capable of producing two toxins (bivalent strains): type 
Ab, Ba, Af, Bf, Bh, and AB. When one of the toxins is produced in a smaller 
amount, it is indicated by a lower case letter. Some strains encode two toxins 
but only form one active toxin (e.g. A(B) strains). Also, variants (subtypes) 
within BoNT/A, B, E, and F have been identified, and designated with the type 
followed by an Arabic number. Recently a strain with three different 
neurotoxin genes was discovered, one type A and two type F subtypes, and it 
produces all three neurotoxins (Kalb et al., 2014). The subtypes were originally 
delineated on the basis of immunological or functional differences, but 
nowadays more on genetic differences (Smith et al., 2005, Hill et al., 2007, 
Carter et al., 2009, Raphael et al., 2010). Two mosaic variants of type C and D 
toxin (type C/D and D/C) have been described, but they are not regarded as 
additional subtypes (Moriishi et al., 1996a, Moriishi et al., 1996b).  
2.1.4 The botulinum neurotoxin  
BoNTs are on one hand the most poisonous toxins known and the causative 
agent of botulism and on the other hand a commonly used drug applied for 
neurological movement disorders and in the cosmetic industry as an anti-
wrinkle remedy (Gill, 1982, Kaji, 2011). BoNT/A became the first biological 
toxin to receive approval for the treatment of human disease (Johnson, 1999). 
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BoNT is a large heat-sensitive protein of approximately 150 kDa, consisting of 
a 50 kDa light chain (LC) and a 100 kDa heavy chain (HC) covalently linked 
by a disulfide bridge (Schiavo et al., 2000). The HC is in its turn composed of 
two domains: the N-terminal domain (HCN) and the C-terminal domain (HCC). 
The BoNT-encoding gene (bont) is part of a gene cluster, which includes 
several accessory genes encoding non-toxic neurotoxin-associated proteins, 
NAPs. Two main bont cluster organizations are known, the hemagglutinin (ha) 
cluster and the orfX cluster. Both include a gene coding for a non-toxic non-
hemagglutinin protein (NTNH), which is more conserved than the bont gene. 
NTNH has a structure highly similar to that of BoNT, and may have evolved 
from a gene duplication of a common ancestor (Inui et al., 2012). The NTNH 
directly interacts with BoNT, thereby shielding sensitive parts of BoNT to 
protect it against the low pH and proteases present in the digestive tract (Niwa 
et al., 2007). Besides the ntnh and bont genes, the ha cluster typically consists 
of three hemagglutinin genes encoding Hemagglutinin (HA) and a botR gene, 
whereas the orfX cluster contains genes encoding proteins of unknown function 
and sometimes botR. The botR encodes a sigma factor 70, which has been 
suggested to regulate expression of genes in the neurotoxin cluster (Sebaihia et 
al., 2007).  
2.1.5 The disease mechanism 
BoNT causes a state of paralysis, and when this happens involuntarily it is 
called botulism. The disease mechanism is illustrated in Figure 2. BoNT does 
not penetrate intact skin but may be absorbed via mucosal surfaces or skin 
lesions (inhalation botulism and wound botulism). In some cases, BoNT is 
produced upon germination in the body (toxicoinfection). This can happen to 
infants (infant botulism) and more rarely to immunocompromised patients, but 
is more common in animal botulism and will be further described later in this 
chapter. However, the primary route for disease is caused by ingestion of pre-
formed BoNT through food or feed. This is sometimes referred to as classic 
botulism, or food-borne botulism. Depending on disease route, BoNT uses 
different entries into the blood stream in order to use the circulation to reach 
nerve endings. In classic botulism, the HA component facilitates adhesion to 
the intestinal epithelial cells and a small amount of BoNT, alone or in complex 
with NAPs, is transported across the epithelium. Next, the HA component 
disrupts tight or adherent junction proteins of the basolateral surface or exerts 
cytotoxic effects on the epithelial cells, which allows for passage of a larger 
amount of BoNT or BoNT complexes (Fujinaga et al., 2009, Jin et al., 2009). 
BoNT dissociates from NTNH upon entry to the bloodstream where the pH 
value is above 7 (Gu et al., 2012). It is then transported through the blood to 
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neurons where it binds to gangliosides, which are enriched at nerve terminals, 
ensuring a high toxin-cell encounter rate (Rummel et al., 2004, Tsukamoto et 
al., 2005). Depolarization in the nerve cell triggered by the ganglioside binding 
initiates vesicle fusion to the plasma membrane and exposes synaptic vesicle 
proteins, which function as specific co-receptors for BoNTs (specific for HCC) 
(Dong et al., 2003, Dong et al., 2006, Dong et al., 2008, Fu et al., 2009, 
Rummel et al., 2009, Strotmeier et al., 2010, Willjes et al., 2013). Upon 
binding, the BoNT-receptor complex is transferred into the lumen of the 
vesicle, and subsequently into the cytosol (Lalli et al., 1999, Koriazova and 
Montal, 2002). Once inside the cytosol, the light chain is released from the 
heavy chain. The light chain is a Zn2+-dependent endopeptidase that cleaves 
specific peptide bonds within neuoronal SNAREs (soluble N-ethylmaleimide 
sensitive factor attachment protein receptors). BoNT/A, C and E cleave 
synaptosomal-associated protein (SNAP-25) at different sites and BoNT/C also 
cleaves syntaxin (Blasi et al., 1993, Binz et al., 1994, Foran et al., 1996). 
BoNT/B, D, F and G cleave the vesicle-associated membrane protein (VAMP), 
each at different sites (Schiavo et al., 1992, Schiavo et al., 1993a, Schiavo et 
al., 1993b, Schiavo et al., 1994). The disruption of SNAREs inhibits the fusion 
of acetylcholine vesicles with the neuronal membrane, thereby preventing 
acetylcholine release. This results in paralysis of the affected muscles. 
 
Figure 2. The mechanism of 
action of botulinum 
neurotoxins (BoNTs). 1) 
BoNT binds to a specific 
receptor and is transferred to 
the inside of the neuronal 
cell by endocytosis. 2) The 
BoNT light chain (LC) 
dissociates from the heavy 
chain (HC) and cleaves 
proteins of the SNARE 
complex. 3) Without BoNT, 
acetylcholine is released 
upon vesicle fusion through 
SNARE binding with the 
neuronal membrane. 4) 
Acetylcholine binding to the 
acetylcholine receptor on the 
skeletal muscle fibre is a 
signal for muscle 
contraction. 
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2.1.6 C. botulinum and BoNT as a biothreat  
Due to the extreme potency, lethality and ease of production, BoNT has been 
considered a potential bioweapon for decades, either to be used in an aerosol 
form or by contaminating food or feed (Gill, 1982). There are multiple 
examples where BoNT has been produced for biological warfare or terrorist 
attacks, although so far unused or used with unsuccessful result as far as we 
know (Arnon et al., 2001). Most of these examples rely on aerosolized BoNT, 
where exposure to the toxin would cause absorption through the lungs. This 
has been shown experimentally in primates (Franz et al., 1993), but also 
occurred accidentally to veterinary personnel in a laboratory in Germany 
(Holzer, 1962). Deliberate contamination of water supplies is generally 
considered as a minor threat since BoNT is rapidly inactivated by standard 
potable water treatments (Siegel, 1993). However, the toxin may be stable for 
several days in untreated water (Siegel, 1993). If food or feed were used as a 
vehicle for BoNT or C. botulinum spores, the outbreak would need to be 
distinguished from naturally occurring botulism outbreaks in order for actions 
to be taken against the crime. Both in the US and within the EU there are 
surveillance systems for human botulism based on clinician reporting, which 
can aid detecting abnormalities or connections between episodic outbreaks 
(CDC, 2012, ECDC, 2014). However, animal botulism is not listed as a 
notifiable disease everywhere and therefore no similar system has been 
developed, thus making animal husbandry more vulnerable (Skarin et al., 
2013).  
Botulism research is also an issue of Dual Use Research of Concern 
(DURC), which is defined by the World Health Organization as research that is 
intended for benefit, but which might easily be misapplied to do harm. Upon 
the discovery and suggestion of a new BoNT type (BoNT/H), the sequence was 
withholded from publication since no antitoxins had yet been developed to 
counteract the novel toxin (Hooper and Hirsch, 2014). However, it can be 
claimed that the hold on information is a greater threat than the sequence itself.  
2.2 Genomics 
The new sequencing platforms have provided an opportunity to gain a deeper 
understanding of the phylogeny within C. botulinum, and to give us new 
insights regarding the evolution and distribution of virulence factors.  
2.2.1 Bacterial genome sequencing 
For decades, Sanger sequencing was the golden standard sequencing 
technology, and it was used to complete the first bacterial genome, 
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Haemophilus influenza in 1995 (Fleischmann et al., 1995). In later years, there 
has been a rapid development of next generation sequencing technologies 
(NGS), which relies on the opportunity to simultaneously read sequences. This 
results in a considerably higher throughput and deeper sequence coverage. The 
lower cost per sequenced base in combination with a faster turnaround-time are 
the main reasons why massive parallel sequencing has caused such a revolution 
in genome sequencing. Three technologies have been dominating for bacterial 
genome sequencing: pyrosequencing (454) (Margulies et al., 2005), reversible-
end sequencing (Illumina) (Bentley et al., 2008) and semiconductor sequencing 
(Ion Torrent) (Rothberg et al., 2011). Although based on different chemistries, 
all require the setup of a DNA library, which is formed by ligating platform-
specific synthetic DNA sequences (adapters) onto the ends of the DNA 
fragments to be sequenced. Next, the library fragments (the template) are 
amplified by a polymerase-mediated reaction and the template is sequenced in 
parallel reactions. In the 454 and Ion Torrent instruments, the amplification of 
template is performed by emulsion PCR onto beads. The beads are loaded onto 
wells that can fit a single DNA-coated bead each. In 454 pyrosequencing, 
nucleotides are added one at the time and the incorporation is detected by the 
light obtained from the release of phosphate molecules. In semiconductor 
sequencing, an ion sensor detects hydrogen atoms as they are released when a 
nucleotide binds in to the complementary strand. The light (in 454) or 
electronic signal (in Ion Torrent) is proportional to the incorporated number of 
nucleotides. In the Illumina technology, the template is amplified by bridge-
amplification directly in the flow cell. All four fluorescently labeled 
nucleotides are added in each cycle, but they are chemically blocked, which 
ensures the incorporation of only one nucleotide per fragment cluster in each 
reaction cycle. This enables the identification of single bases as they are 
introduced into DNA strands. As the 454 technology is on its way out of the 
market, a new long-read technology from Pacific Biosciences (PacBio) is 
uprising. PacBio is a single molecule real time (SMRT) sequencing technique, 
which by providing reads longer than the longest repeat in a microbial genome 
can result in an assembly of a single contig (Koren et al., 2013).  
The fragmenting of DNA to be sequenced by NGS results in random 
sequencing start points, which has the advantage that the sequencing output 
consists of overlapping sequences. These can be combined into a longer 
sequence, i.e. a contiguous sequence (contig). There are areas in the genome 
which will result in sequences of poor quality. Further, areas with repetitive 
sequences and genes existing in multiple copies in the genome, such as 
ribosomal RNA and transposons, cause additional problems as they result in 
sequences that can be combined in several ways. Therefore, in order to cover 
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and combine sequences of a genome into a complete genome (i.e. de novo 
sequencing), additional bioinformatics processing and Sanger sequencing is 
usually required. A genome that is not fully covered or still consists of multiple 
contigs is defined as a draft genome. 
2.2.2 C. botulinum genomics 
Already biochemical analysis and later 16S rRNA sequencing showed that C. 
botulinum encompasses genetically diverse strains (Figure 3) (Lee and 
Riemann, 1970, Cato et al., 1982, Nakamura et al., 1983, Hill et al., 2007). 
Some strains are capable of digesting complex peptides and are identified as 
proteolytic, whereas others are non-proteolytic. The growth temperature 
requirements also differ between strains and so does the spore sensitivity to 
heat and chemicals. With the increased amount of genetic information about C. 
botulinum strains, it was eventually proposed to divide C. botulinum into four 
different physiological and genotypic groups, I-IV (Table 2).  
Table 2. Characteristics of C. botulinum groups I-IV (Smith and Hobbs, 1974, Miyazaki and 
Sakaguchi, 1978, Lindstrom and Korkeala, 2006, Carter and Peck, 2015)  
 Group I Group II Group III Group IV 
BoNT subtype  A1-A5, B1-B3, 
F1-F5 
B4, E1-E3, E6-E9, 
F6 
C, D, (C/D, D/C) G 
Proteolytic 
capability  
Yes No Mixed Weak 
Optimum growth 
temperature (°C)  
35-37 26-30 30-42 30-37 












In recent years, strains of additional Clostridium species have been found 
capable of producing botulinum neurotoxins, although they have kept their 
original species designations: Clostridium butyricum and Clostridium baratii 
(Hall et al., 1985, Aureli et al., 1986). These strains, which can produce 
BoNT/E (subtype E4 and E5) or BoNT/F (subtype F7), respectively, have been 
suggested to be classified as C. botulinum group V and VI. As the amount of 
genetic information from clostridia species has increased, the different groups 
of C. botulinum have been discovered to be more closely related to other 
clostridia species than to remaining C. botulinum groups (Figure 3). For 
example, C. botulinum group I is closely related to C. sporogenes and C. 
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botulinum group III to C. novyi and C. haemolyticum (Sasaki et al., 2001, Hill 
et al., 2007).  
 
Figure 3. Phylogenetic dendrogram of Clostridium species illustrating the genetic diversity of C. 
botulinum. The neighbour-joining tree was constructed using an alignment of 1,329 bp of 16S 
rRNA gene sequences. Modified from Hill et al. (Hill et al., 2007) with permission. 
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The first completed whole genome sequence from C. botulinum was published 
in 2007 and was from a Sanger sequenced type A strain, ATCC 3502 (Sebaihia 
et al., 2007). Additional sequencing projects for strains representing other 
types of C. botulinum were soon initiated and to date there are 81 C. botulinum 
genomes available in GenBank, out of which 19 are completed genomes 
(GenBank, 2015). The genomes so far sequenced of group I strains 
demonstrate a distinct genetic lineage when compared to genomes of the other 
C. botulinum groups and display only minor insertions/deletions when 
compared to each other (Carter and Peck, 2015). There are fewer completed 
group II genomes available for analysis, but the diversity between group II 
genomes is larger than what is displayed in group I (Carter and Peck, 2015). In 
group II, genomes of type B and F strains are highly related, whereas type E 
strains form a separate genetic linage upon whole genome analysis (Stringer et 
al., 2013). Prior to the projects described in this thesis, there were no complete 
genomes of C. botulinum group III or IV available for analysis. 
2.2.3 Mobile genetic elements and horizontal gene transfer 
Transfer of DNA between cells is called horizontal gene transfer, and the 
mobilization is usually mediated by mobile genetic elements such as plasmids, 
bacteriophages, and transposable elements. This genetic transfer can have a big 
impact on bacterial genomes as it may affect fitness and pathogenicity by 
adding or removing accessory genes. Clostridia pathogens are well known for 
their ability to produce powerful toxins, e.g. the Clostridium tetani toxin 
(TeTx), the Clostridium perfringens epsilon toxin, the C. novyi alpha-toxin and 
the C. botulinum BoNT. Thanks to whole genome sequencing of clostridia 
genomes, the locations of these toxin genes have been identified. Several are 
located on plasmids (tetx and the C. perfringens epsilon toxin gene) or 
bacteriophages (C. novyi alpha-toxin). The bont cluster is organized in 
different positions on the chromosome or on different plasmids in C. botulinum 
group I and II strains, on large plasmid-like prophages in group III strains, and 
on plasmids in group IV strains (Table 2). The difference in location of bont, in 
combination with the high overall genetic diversity of the physiological groups, 
has led to the suggestion that bont has been horizontally transferred between 
different species of bacteria. On the basis of sequence and structural 
similarities, Collins and East suggested that there was a single ancestral form to 
both BoNT and TeTx (Collins and East, 1998). Assuming a similar rate of 
nucleotide change, they further proposed that the ancestral toxin ended up in 
three or four clostridia subpopulations, which later became C. tetani, C. 
botulinum group III, and C. botulinum group I and II (or group I and II 
independently). The clustering of group I strains is less correlated with 
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neurotoxin type than the clustering of group II strains, suggesting a more 
frequent horizontal transfer of the bont cluster between strains of group I than 
of group II (Carter and Peck, 2015).  
 There are several mechanisms that most likely have played parts in the 
neurotoxin gene transfer and altering events, including conjugation, 
transduction, transposition and recombination. Conjugation has been 
demonstrated by a BoNT-encoding plasmid (pCLL) from a C. botulinum group 
II strain to a nontoxigenic C. botulinum group I strain, thus proposing a bridge 
between these two genetically diverse groups (Marshall et al., 2010). Further, 
the BoNT-encoding phages of C. botulinum group III have been demonstrated 
capable of infecting non-toxigenic strains of either type C or D strains (Eklund 
and Poysky, 1974).  
Different complete or truncated transposons have been discovered around 
or within the bont cluster, suggesting a role in the event of transfer (Hill et al., 
2009). Transposable elements use different mechanisms for translocation, for 
example an RNA intermediate (retrotransposons), a phage y-type mechanism 
(conjugative transposons) or a “cut and paste” mechanism (insertion sequence 
elements). Insertion sequence (IS) elements are short DNA sequences (<2,5kb) 
mainly encoding genes (recombinases/transposases) needed for their own 
excision and insertion (Mahillon and Chandler, 1998). Among the clostridia 
species, the C. difficile genome contains a large proportion (11% of its 
genome) of transposable elements, which mainly constitutes of conjugative 
transposons (Sebaihia et al., 2006), and IS elements are abundant in some C. 
perfringens genomes (Myers et al., 2006). To the contrary, transposable 
elements are scarce and mostly non-functional in genomes of C. 
acetobutylicum (Nolling et al., 2001), C. tetani (Bruggemann et al., 2003) and 
C. botulinum group I (Sebaihia et al., 2007).   
Mosaic bont genes appear to be products of recombination events, for 
example the chimeric type C/D and D/C bont genes in C. botulinum group III 
strains (Moriishi et al., 1996b). Further, BoNT/A2, BoNT/E6 and BoNT/F5 
also appear to be hybrids, which include toxin sequences of other bont 
subtypes and/or unique parts (Chen et al., 2007, Raphael et al., 2010, Hill and 
Smith, 2013). Last, the ntnh gene that precedes bont has also been identified as 
a region of recombination between sequences from different bont clusters, for 
example the hybrid ntnh consisting of one part from ntnh of type C and one 
part from type A (Kubota et al., 1996). 
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2.3 Animal Botulism 
The diagnosis of animal botulism is often based on clinical signs and seldom 
laboratory confirmed, which leads to uncertainty of the prevalence of the 
disease and of responsible BoNT type. However, among reported cases of 
animal botulism, BoNT/C, D and the mosaic types C/D and D/C, are 
dominating. Other BoNT types can also cause botulism in animals, for example 
type A and B cause botulism in cattle and horses, and type E causes botulism 
in fish and fish-eating birds (Table 1) (Yule et al., 2006, Johnson et al., 2010, 
Lindstrom et al., 2010, Johnson et al., 2012). The variation of BoNT type 
causing animal botulism depends to some extent on the distribution of the 
spores. For example, C. botulinum type E spores are mainly found in aquatic 
environments, whereas type B spores are more commonly found in soil (Huss, 
1980). The geographical presence of the different types in soil also vary (Ortiz 
and Smith, 1994). There are also significant differences in susceptibility 
towards the different BoNT types. For example, avian species are much more 
sensitive to type C/D than to type C or D (Miyazaki and Sakaguchi, 1978, 
Takeda et al., 2005). Further, bovine neuronal cells seem to be more sensitive 
to type D/C than to type C or D (Nakamura et al., 2012). The difference in 
susceptibility can to some extent be explained by the varying abilities of the 
different BoNTs to pass through the digestive tract in different species. It has 
for example been shown that the HA component binding to adhesion proteins 
(E-cadherins) is species specific. The HA of BoNT/C does not interact with 
human E-cadherin and the HA of BoNT/B does not interact with chicken E-
cadherin, both consistent with the epidemiology of botulism (Sugawara et al., 
2010).  
2.3.1 Disease routes 
As in humans, many cases of animal botulism are caused by ingestion of pre-
formed toxin, i.e. the disease is due to an intoxication. Animals may directly 
ingest toxin-contaminated material, such as water or feed, or they may ingest 
toxins through the consumption of zooplankton or invertebrates that have 
consumed toxic material. Bovine and equine botulism are often related to the 
presence of carcasses or litter of poultry or wild birds, in combination with 
poorly preserved silage (Lindstrom et al., 2010).  
In toxicoinfection, there is a ceacal colonization of C. botulinum resulting in 
an in situ production of BoNT. In avian species, botulism is often caused by 
the subsequent digestion of caecal droppings containing high concentrations of 
BoNT (Miyazaki and Sakaguchi, 1978, Hyun and Sakaguchi, 1989). 
Toxicoinfection can also cause disease in young animals, such as foals (shaker 
foal syndrome) (Swerczek, 1980). It has further been proposed to be 
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responsible for paralytic symptoms called “visceral botulism” or “equine grass 
sickness” in cattle and horses, respectively, but this has not been conclusively 
confirmed (Hunter et al., 1999, Bohnel et al., 2001, Seyboldt et al., 2015). 
Spores are not uncommonly found in fecal samples of healthy animals, 
indicating that there are certain criteria necessary for establishing a 
toxicoinfection (Notermans et al., 1981, Dahlenborg et al., 2001, Blomqvist et 
al., 2009). These animals, and especially birds, may spread C. botulinum 
spores from epizootic areas to previously uncontaminated areas. Remains of 
poultry or poultry manure have been suspected sources of botulinum spores or 
BoNT in many animal botulism outbreaks (Hogg et al., 1990, Lindstrom et al., 
2004, Livesey et al., 2004).  
2.3.2 Avian botulism 
The first described cases of avian botulism were referred to as “Limberneck 
disease” or “Western Duck Sickness”, as affected birds get a hanging neck and 
early cases were discovered in the Western part of the United States 
(Windingstad and Laitman, 1988). In 1930 it was concluded to be a form of 
botulism (Giltner and Couch, 1930), and since then avian botulism has been 
diagnosed in wild birds on all the continents, except the Antarctic (Jensen and 
Price, 1987). Especially big and recurring outbreaks in wild birds have been 
reported from the Great Lakes region in the United States (Lan Chun et al., 
2015), from Incheon in South Korea (Shin et al., 2010), from wetlands in 
central Spain (Figure 4A) (Vidal et al., 2013), and from the southeast coast of 
Sweden (Neimanis et al., 2007). Although the outbreaks around the Great 
Lakes tend to be caused by BoNT/E, avian botulism is most commonly caused 
by type C or C/D. Avian botulism also occur in domestic birds and there are 
numerous reports of botulism outbreaks in poultry from around the world. The 
first confirmed botulism outbreak in broiler chickens in Sweden was in 2003, 
and since then there have been several outbreaks every year. The highest 
number of outbreaks in Sweden occurred in 2008 when 13 different broiler 
farms were affected (Blomqvist et al., 2009). A botulism outbreak was also 
recently described in commercial laying hens in Sweden (Figure 4B) (Skarin et 
al., 2015).  
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Figure 4. Birds paralysed with botulism. A) Mallards, Spain (Photo: Rafael Mateo, IREC) B) 
Laying hen, Sweden (Photo: Désirée Jansson, SVA).  
2.3.3 C. botulinum group III virulence factors 
The bont-phage  
That BoNT/C toxin production was governed by bacteriophages was suggested 
already in 1970 (Inoue and Iida, 1970). Soon after, the first phages were 
isolated from C. botulinum type C strains. It was demonstrated that 
nontoxigenic strains can be easily derived by treating cultures with UV 
irradiation (Eklund et al., 1971). Hariharan and Mitchell examined 
supernatants of C. botulinum type C strains by electron microscopy and found 
three different types of tailed phages: a larger, a smaller and an intermediate 
type with a head of the smaller size but with a tail of the larger size (Hariharan 
and Mitchell, 1976). Mainly the large, but also the intermediate phage, have 
been connected to BoNT production. The toxin is produced during the 
lysogenic state and the balance between lytic and lysogenic state seems to be 
the main reason to the varying degree of toxicity between strains (Hariharan 
and Mitchell, 1976).  What affects this balance is not known, but 
environmental factors are probably involved. For example, the bont-phage is 
more prone to start a lysogenic relationship with the bacterium at 30°C than at 
37°C. Further, less dense cultures are infected at a higher rate than older 
cultures (Eklund et al., 1987). 
Phages from different C. botulinum group III strains, capable of producing 
either type C or D toxin, have been demonstrated to be able to infect 
nontoxigenic strains, even if the strain originally was able to produce the other 
toxin type. However, some strains are insensitive to phages from another 
strain, or become only weakly toxic (Eklund and Poysky, 1974). Also, alpha-
toxin encoding phages isolated from C. novyi type A supernatants are able to 
infect and produce toxin in both toxigenic and nontoxigenic C. botulinum type 
C and D strains (Eklund et al., 1974). 
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The bont-phage is not integrated into the chromosome but resides in the 
cytoplasm as a large circular prophage during the lysogenic state (Sakaguchi et 
al., 2005). The discovery of such phage-like plasmids are emerging with the 
number of genomes being analysed, and they are described for example also in 
Streptomyces (Zhong et al., 2010) and Salmonella (Octavia et al., 2015). 
The C2 and C3 toxins 
In addition to BoNT, two ribosylating exoenzymes, the C2 and C3 toxin, have 
been described in C. botulinum, both being produced solely by C. botulinum 
group III strains. Experiments in animals have shown that they exhibit 
enterotoxic properties, but their role in animal botulism is still not clear 
(Ohishi, I., 1983). The C2 toxin is composed of two polypeptide chains: one is 
the binding component and the other is the enzymatic component, which 
catalyzes the ADP-ribosylation of nonmuscular G actin (Aktories et al., 1986). 
The C3 toxin acts on the Rho protein (Aktories et al., 1989). The genes 
encoding these two toxins are carried on mobile elements. The binary C2 toxin 
genes are plasmid-borne, and the gene encoding the C3 toxin is located on the 
bont-phage (Popoff et al., 1990, Sakaguchi et al., 2009). Further, the C3 toxin 
gene has been proposed to be located on a transposon of 21.5kb, as its 
surrounding sequence bares similarities with site-specific transposons and 
since this 21.5 kb sequence is more conserved than the rest of the phage 
(Hauser et al., 1993). Also, this 21.5kb fragment was missing in a phage 
mutant obtained by nitrosoguanidine treatment (Oguma et al., 1975, Hauser et 
al., 1993).  
2.3.4 Diagnostics 
The diagnosis of animal botulism is often made by the veterinarian on the basis 
of clinical signs and the absence of diagnostic postmortem findings. For 
laboratory confirmation, it is considered essential to detect active botulinum 
neurotoxin, and the golden standard method is still the mouse bioassay (Tevell 
Aberg et al., 2013). In this method, samples to be tested are injected into mice, 
which are observed for symptoms of botulism. The toxin type can also be 
determined by injecting the sample along with an antitoxin and observe the 
mice for symptoms of botulism. The advantage by this method, which has 
made replacement difficult, is the high sensitivity (1 mouse lethal dose is 
approximately 10 pg) (Grate et al., 2010). However, in the past decade, several 
new methods aiming to replace the mouse bioassay have been developed. 
Some of those are based on the protease activity of BoNTs, for example mass 
spectrometric detection of the BoNT cleavage products (Hedeland et al., 2011, 
Kalb et al., 2015).  
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Detection of bont type C, D or mosaic C/D and D/C genes 
Besides detecting the toxin, there are also different Polymerase Chain Reaction 
(PCR) methods developed for detection of bont. PCR is a method used for 
amplification of a sequence, which allows for DNA detection by staining 
(conventional PCR) or emitted fluorescence as the DNA is being amplified 
(real-time PCR). A cultivation step to enrich for anaerobic spore-formers is 
usually required prior to bont detection by PCR (Lindstrom and Korkeala, 
2006). The first PCR method developed for a C. botulinum group III strain was 
developed in 1992 for the bont/D gene (Sunagawa et al., 1992), followed by 
bont/C (Szabo et al., 1993). Now there are many conventional and real-time 
PCR methods developed for detection of bont genes in C. botulinum group III 
strains. The first PCR method that was able to differentiate between type C, D 
and the mosaic types C/D and D/C genes was developed by Takeda et al. and 
was a conventional PCR (Takeda et al., 2005). Several multiplex real-time 
PCR methods have been developed within the AniBioThreat project to fasten 
and simplify the diagnostics of animal botulism by being able to differentiate 
between type C and D, or type C/D and D/C (Woudstra et al., 2012) or 
between all four C. botulinum group III bont types (Anniballi et al., 2013). 
Isolation and genotyping methods 
The isolation of C. botulinum group III is generally known to be difficult, 
partly due to the strict anaerobic metabolism and lack of known selective traits, 
but also because of the instability of the bont-phage, since bont detection often 
is used for species confirmation. The epidemiology of strains causing animal 
botulism is to a large extent unknown, mainly because of the difficulty to 
isolate pure cultures of C. botulinum group III.  
Today different targeted PCR-based approaches for genotyping of bacteria 
are common, e.g. Multilocus sequence typing (MLST) (Perez-Losada et al., 
2013) and Multiple-Locus Variable number tandem repeat Analysis (MLVA) 
(Lindstedt, 2005). However, the epidemiological studies performed so far 
concerning animal botulism outbreaks have applied more traditional 
genotyping techniques: pulsed-field gel electrophoresis (PFGE), amplified 
fragment length polymorphism (AFLP), and randomly amplified polymorphic 
DNA analysis (RAPD) (Grenda et al., 2014). The main advantage with those 
techniques is that they can detect genetic variations in the whole genome 
without any prior knowledge of the genetics of the organism. In PFGE, 
genomic DNA is fragmented by a restriction enzyme and size distributed by 
applying an electric field that constantly changes direction, which allows for 
separation of very large fragments (Figure 5). AFLP is a PCR-based method, in 
which restriction fragments of genomic DNA are amplified prior to separation 
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and comparison, usually by automated capillary sequencing instruments. 
RAPD is another PCR-based method, where a low annealing temperature and 
only one non-specific short primer (usually 10 bp) is applied to achieve 
random amplification.  
 





3 Aims of the thesis 
This thesis project was part of the European collaboration project 
AniBioThreat. The main objective of the thesis was to increase the knowledge 
about C. botulinum group III strains causing animal botulism, and especially 
avian botulism, with a special focus on European strains. More specifically, the 
aims were: 
 
 To develop methods for isolation and molecular characterization of C. 
botulinum group III strains  
 To isolate and characterize C. botulinum group III strains from animal 
samples 
 To investigate the genomic diversity of C. botulinum group III strains  
 To study the genomic organization of C. botulinum group III strains  
 To explore the genomic relationship between C. botulinum group III, C. 
novyi and C. haemolyticum  
 
The first aims to develop methods for isolation and characterization of C. 
botulinum group III strains and the application of these methods are mainly 
covered by paper I and II. However, the strains collected during this thesis 
project are also the basis for paper III and IV. To investigate the genomic 
diversity of C. botulinum group III strains causing animal botulism has in one 
way or the other been the aim in all papers included in this thesis. The C. 
botulinum group III genomic organization has been investigated in detail in 
paper III and IV. The genomic (and more specifically plasmidomic) 
relationship between C. botulinum group III, C. novyi and C. haemolyticum is 







4 Comments on Materials and Methods 
4.1 Isolates 
4.1.1 Sampling materials 
Many of the C. botulinum strains isolated in this thesis project are isolated 
from avian samples from the vast number of avian botulism outbreaks in 
Sweden (both in wild birds and poultry) since 2003. Some isolation material 
from animal botulism outbreaks was received from other partners of the 
AniBioThreat consortium. Both the Norwegian and the Danish strains were 
isolated from samples sent to The National Veterinary Institute (SVA) for bont 
detection analysis. The South Korean strain was isolated from a pig liver 
sample by the author during a visit at the Animal and Plant Quarantine Agency 
in South Korea. The Spanish strains, obtained from avian samples collected at 
three different wetlands in central Spain, were isolated at SVA in collaboration 
with the Spanish PhD student Ibone Anza Gomez. Most of the C. novyi and C. 
haemolyticum strains used in this study, were either obtained from culture 
collections or received from other researchers. One C. novyi strain was isolated 
from a sample collected at a botulism outbreak in broiler chicken in Sweden.   
4.1.2 Cultivation  
Broth cultivation procedures were adopted from previous studies at SVA, but 
the composition of the tryptose-peptone-glucose-yeast extract (TPGY) broth 
had to be adjusted. Sodium thioglycolate was originally used as oxygen 
reducing agent, but as the C. botulinum strains suddenly stopped growing in 
broth and this compound is known to sometimes inhibit growth, the reducing 
compound was changed into a mixture of cysteine hydrochloride (cysteine-
HCl) and sodium bicarbonate (NaHCO3) (Segner et al., 1971). Similarly, the 
McClung Toabe agar (McClung and Toabe, 1947) used for cultivation on agar 
plates was also supplemented with cysteine-HCl and NaHCO3. Normally 1 g of 
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sample material was inoculated into 9 ml of pre-reduced broth and this was put 
in a water-bath at 70°C for 15 min to kill vegetative cells. The sample was then 
incubated for 2 days at 37°C. C. botulinum group III strains can grow in a 
broad temperature range, from 10 to 47°C (Mitchell and Rosendal, 1987). A 
lower incubation temperature (30°C) has been used for marine strains (Segner 
et al., 1971) whereas a higher temperature (42°C) may be relevant for avian 
strains reflecting the body temperature of birds. The temperature of 37°C was 
chosen to provide for growth of all kinds of strains connected to animal 
botulism. Incubation was either done inside an anaerobic cabinet or in 
anaerobic jars. 
4.1.3 Isolation 
The largest challenge during the isolation process was the competing flora and 
it was therefore found necessary to pre-heat the samples in order to select for 
spore-formers. Cultures were prepared as in 4.1.2 and processed after a 
minimum of 24 hours to ensure the presence of spores. Initially isolates were 
obtained by many re-streaks to obtain single and pure colonies. This was often 
unsuccessful. Instead, antibodies were produced (by Innovagen) towards 
spores of six different C. botulinum type C and C/D strains. A portion of spore-
containing material was mixed with antibodies labeled with biotin. The spore-
antibody complex was then coupled to streptavidin-coated magnetic beads and 
extracted from the sample using magnetic force. The procedure is further 
described in paper II. As antibodies were produced against complete spores, 
they are likely not specific for C. botulinum spores, but rather bind to spore 
coat proteins also in spores from other bacteria. However, this 
immunomagnetic separation (IMS) technique was found valuable to decrease 
competing flora and provided for isolation of the majority of the isolates 
obtained during this thesis project. 
4.1.4 Identification of strains 
After learning how to recognize them, C. botulinum group III colonies were 
usually easily detected on the McClung agar containing egg yolk, on the basis 
of colony morphology. Especially due to the iridescent sheen due to lipase 
activity and an opaque precipitate surrounding the colony due to lecithinase 
activity. However, the colonies from a pure culture sometimes had a mixed 
morphology: they could be smooth or have a sprawling appearance with or 
without the surrounding precipitation (Figure 6A). C. botulinum group III 
strains have mixed proteolytic capabilities and this may cause a difference in 
colony morphology (Smith and Hobbs, 1974). This was not confirmed as these 
strains were not analysed for proteolytic capability, however it seems unlikely 
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that different colonies from the same strain would have different proteolytic 
capability. It was established that the difference in morphology did not 
correlate with loss of the bont-phage. It has been claimed that by using the 
McClung egg yolk agar it should be possible to distinguish between C. 
botulinum group III strains and C. novyi type B and C. haemolyticum strains 
(McClung and Toabe, 1947). Considering the mixed morphology sometimes 
present in a culture, it was found impossible to make such a distinction. 
C. botulinum group III strains growing in TPGY broth sink to the bottom of 
the tube as they reach stationary growth phase and they do not leave a bad 
smell (Figure 6B). Turbid growth and a foul smell were always signs of 
contamination in an overnight culture. 
 
Figure 6. Cultures of C. botulinum group III. A) Colonies of mixed morphology on McClung 
Toabe agar. B) Culture in tryptose-peptone-glucose-yeast extract broth. 
C. botulinum and C. novyi strains were primarily identified upon the presence 
of bont and the C. novyi alpha-toxin gene, respectively. The PCR protocol 
mainly used for bont detection in this thesis detects bontC and bontC/D 
(Lindberg et al., 2010). The two C. haemolyticum strains used in the study 
were type strains. Since it was sometimes difficult to identify strains on the 
basis of toxin genes due to phage loss during the isolation process, a 
chromosomal PCR was designed to be used in addition to toxin gene profiling. 
This PCR (described in paper II) specifically detects the gene encoding the 50S 
ribosomal protein L10 of C. botulinum group III, C. novyi and C. 
haemolyticum.   
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4.2 DNA extraction 
DNA of some clostridia species has been noted to be easily degraded by 
endogenous DNases (Kristjansson et al., 1994). C. botulinum is clearly one of 
those species, as purified genomic DNA run on an agarose gel typically results 
in a smear of degraded DNA. This is usually not a big problem for DNA to be 
used in a PCR analysis as it does not require long pieces of DNA. For this 
purpose, DNA was extracted either by boiling, by the DNeasy blood-and-tissue 
kit (Qiagen, Germany), in the BioRobot EZ1 workstation (Qiagen) or in the 
case of a large number of samples by using Magattract DNA mini M48 kit 
(Qiagen) in the Magnatrix automated nucleic acid extraction machine 
(NorDiag). However, whole genome sequencing required a higher 
concentration of high quality DNA. The DNA extraction kit that generated the 
best result for this purpose was the MasterPure Gram Positive DNA 
Purification Kit (Epicentre Biotechnologies, USA). 
4.3 Genotyping  
PFGE is considered the primary technique for genotyping C. botulinum strains 
as it is applied in various laboratories throughout the world, and 
standardization (i.e. through PulseNet) has enabled comparisons between 
different laboratories. PFGE was chosen as the main genotyping technique in 
this thesis project for several reasons: required equipment was available, it is 
functional for inter-laboratory comparability of generated results, and it does 
not require any previous sequence information. However, PulseNet protocols 
recommended for C. botulinum group I or II strains (CDC, 2013) could not be 
applied for group III strains. The cell lysis buffer and ES buffer were basically 
the same, except mutanolysin, which had no effect on group III strains, was 
removed. The main adjustments to the protocol were the fixation of cells in 
formaldehyde, which decreased endogenous DNase activity, and the use of 
HEPES buffer instead of a Tris-containing buffer for electrophoresis. Without 
those two changes the bands were barely visible or only a smear. This is shown 
in Figure 1 in paper I. Still not all strains were typeable by PFGE. AFLP, 
which requires much smaller DNA fragments than PFGE, might have been a 
safer choice for genotyping. However, banding patterns generated by AFLP are 
also affected by poor DNA quality (Vuylsteke et al., 2007).  
Two restriction enzymes, SmaI and SalI, were chosen for PFGE restriction 
analysis on the basis of the number of bands produced and their discriminatory 
ability. Since SmaI is more commonly used for other PFGE analysis, it was 
continuously used for genotyping of C. botulinum group III strains.  Between 7 
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and 15 bands (25-407 kbp) were produced by PFGE of the analysed C. 
botulinum group III strains.  
A protocol for RAPD was also optimized for C. botulinum group III strains 
in order to have a faster genotyping method than PFGE available (one day 
compared to five days). The RAPD method was as discriminatory and 
reproducible as the PFGE analysis when only including strong bands. 
However, there were many weaker bands generated, which made the results 
more difficult to interpret.  
4.4 Sequencing and assembly 
4.4.1 Sequencing technology 
The main advantage with 454 sequences to be used for de novo assembly is the 
read length (<1kb for GS FLX Titanium) (Roche, 2015), which overruns the 
ones generated by the Illumina (250 bp for HiSeq and 250 or 300 bp for 
MiSeq) (Illumina, 2015) and Ion Torrent instruments (400 bp) 
(LifeTechnologies, 2015). The PacBio RS II platform generate the longest 
sequences, with an average read length of 10-15 kb (PacBio, 2015). However, 
the latter technology could not be used in this project due to the requirements 
of unfragmented DNA. Therefore the first genomes that were sequenced in 
these studies were sequenced with 454 sequencing at the Science for Life 
Laboratory (Stockholm, Sweden). Remaining genomes were sequenced on 
Illumina MiSeq (2x250 bp) because of the lower price and easier access (an 
instrument was installed at SVA). Besides, the MiSeq sequences provide 
paired-end information, which is useful for the assembly program to accurately 
assemble sequences into contigs. The high sequence throughput generated by 
Illumina HiSeq was used to correct errors in completed plasmids. 
4.4.2 Genome assembly 
All genomes were de novo assembled as the abundance of IS sequences and 
variations in the genomes made reference-guided assembly unsuitable. 
However, the sequence of the chromosome from C. novyi-NT (GenBank 
accession CP00382) was used for guidance when ordering contigs in the C. 
botulinum BKT015925 genome. The generated 454 sequences were assembled 
using GS assembler (Newbler, Roche applied science). Sequences generated by 
MiSeq were assembled using two different open source software packages: 
MIRA (Chevreux et al., 2004) and SPAdes (Bankevich et al., 2012). SPAdes 
was found to be the best choice of assembly program for MiSeq sequences 
from C. botulinum group III strains, resulting in the lowest number of contigs. 
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Contigs were further processed and assembled using Consed (Gordon et al., 
1998). 
4.4.3 Plasmid assembly 
First, uncleaved genomic DNA was separated on an agarose gel by PFGE in 
order to get an estimate of the number and size of plasmids in each strain. 
Originally S1 nuclease was used to linearize the plasmids but this step was 
removed as the DNA was sufficiently nicked by endogenous DNAses to be 
able to migrate in the gel. Different approaches were used in order to identify 
sequences belonging to plasmids. First, plasmid DNA was separated from 
genomic DNA by using plasmid purification kits: plasmid mini kit (Qiagen) 
and NucleoBond PC20 (Macherey-Nagel, Germany). However, this resulted in 
a DNA concentration too low for sequencing. Instead, strains were cured from 
plasmids by a combination of heat and novobiocin treatment (McHugh and 
Swartz, 1977). Sequences from the cured strains were compared to sequences 
from corresponding wild type strains and differing sequences were identified 
as plasmid DNA.  
4.4.4 Annotation 
Open reading frames (ORFs) in the completed genome and plasmid sequences 
were identified with Glimmer (Delcher et al., 1999). Well-conserved genes 
were automatically annotated from other clostridia genomes and previously 
annotated C. botulinum group III plasmids. Automatic annotations were 
provided on the basis of both identity (>60%) and coverage (>90%) of match 
to annotated reference sequences. Less certain annotations were manually 
assigned by protein alignments using the basic local alignment sequence tool 
(BLAST) against the NCBI non-redundant protein sequences database. Protein 
sequences were further analysed for conserved domains by SwissProt.   
4.5 Genome comparative analysis 
The Gegenees software (Agren et al., 2012), which uses a fragmented 
approach to make all-against-all BLASTN whole genome comparisons, was 
used to perform the phylogenomic analysis of genomes and plasmids. For 
whole genome comparative analysis, the average normalized BLAST scores 
from comparisons of all 200 bp fragments could be used as a measurement of 
overall genomic similarity. Upon plasmid comparative analysis, a threshold of 
40% was used to define the relative amount of conserved sequences (as 
fragments falling under that threshold are not included in the average similarity 
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value). The phylogenomic overviews were illustrated by heat-plots (such as 
Figure 7B).  
MUMmer (Kurtz et al., 2004) was used for genome and plasmid 
comparisons and the Mauve Genome Alignment software (Darling et al., 2010) 
and the Artemis Comparison Tool (Carver et al., 2005) were used for plasmid 
alignments.  
4.6 Plasmid analysis 
A PCR system detecting the different plasmids characterized in paper III was 
used to screen for plasmids in closely related unsequenced strains. Three or 
four primer pairs were chosen for each plasmid: two targeting plasmid 
replication/partitioning genes, and one or two targeting putative virulence 
genes. Detection of genes was performed using PerfeCTa SYBR® Green 
SuperMix Low ROX (Quanta BioSciences) and real-time PCR as described in 
paper II. Conjugation was investigated using the ClosTron mutagenesis system 
(Heap et al., 2007). The p3BKT015925 plasmid was tagged with a group II 
intron, ensuing erythromycin resistance, and mixed with a C. novyi type A 
strain (07-BKT029909). Conjugants should be able to form colonies in the 





5 Results and Discussion 
5.1 Collection and identification of strains (paper I, II and IV) 
To be able to study the genomic organization and diversity of C. botulinum 
group III it was of importance to have a representative strain collection. Before 
the work of this thesis project begun, there was only one C. botulinum group 
III strain in the SVA culture collection of bacterial strains, the C-Stockholm 
strain, which was isolated from mink in 1949 when SVA was located in 
Stockholm (Dinter and Kull, 1951). This strain is now used as a reference 
strain by many laboratories around the world. However, as C. botulinum group 
III strains are known to be difficult to isolate, this was the first challenge.  
Most of the isolates obtained in this work originate from avian samples, 
partly because the majority of the samples were from avian botulism outbreaks, 
but also because birds diseased from botulism more often than other animals 
have had an in situ proliferation of C. botulinum, and therefore are more likely 
to contain the bacteria. From the avian samples, it soon became evident that it 
was much easier to isolate pure cultures from liver samples than from caecum 
samples due to the low amount of contaminating flora present in the liver. 
However, not all the birds diseased from botulism and with C. botulinum 
present in the caecum had spores in the liver. The presence of competing flora 
was the largest problem when isolating pure cultures since C. botulinum was 
easily overgrown by other better growing species. It was therefore a big 
advantage to work with samples that had been collected shortly after death and 
preserved cold. The scarcity of such well-kept animal samples from cases with 
a diagnosis of botulism contributed to the challenge of isolation. Pre-heating 
and eventually also IMS targeting C. botulinum spores were found to be 
beneficial to obtain samples with as little competing microbes as possible. 
Another problem that arose during the isolation of strains was the inability to 
identify strains when they had lost the phage carrying the bont gene. The more 
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difficult samples, which required several re-streaks, had an increased risk of 
losing the phage. It was noticed that some strains lost the phage easily, whereas 
others, such as the C-Stockholm strain, have kept the phage for many 
generations. We know that the lytic cycle of the phage to some extent is 
triggered by environmental factors, but it is not known how the lysogenic 
relationship with the host differs between strains. 
In total, 42 C. botulinum group III strains were obtained during the work of 
this thesis, the majority being of Swedish avian origin. But the collection also 
comprised avian strains from Norway, Denmark and Spain, bovine strains from 
Italy and The Netherlands, and one porcine strain from South Korea. All the 
avian strains isolated were of type C/D and two of the three bovine strains were 
of type D/C. In a related study performed during the work of this thesis it was 
discovered that among samples naturally contaminated with C. botulinum 
spores collected in France, Italy and the Netherlands, only chimeric types could 
be detected (Woudstra et al., 2012). The majority of samples positive for 
bontC/D originated from avian species, and bontD/C from bovine species, but 
there were also some cases of vice versa. These chimeric types were first 
described in the 1990’s (Moriishi et al., 1996a, Moriishi et al., 1996b) and 
today it seems that they are much more commonly involved in botulism 
outbreaks than type C or D strains. This is probably to some extent an effect of 
the improved diagnostics that differ between type C, D and mosaic forms, but 
may also be because they are more toxic to their host than either type C or D 
(Takeda et al., 2005, Nakamura et al., 2012). 
5.2 Genomic diversity in C. botulinum group III (paper I, II, III 
and IV) 
Genomic diversity plays an important role in the adaptability and survival of a 
species. However, C. botulinum dormant spores have little need for adaptation, 
and strains of this species are generally associated with a living host only 
during short periods, which may explain the relatively stable genomes of C. 
botulinum group I and II strains. At the onset of the work of this thesis, very 
little was known about the genomic diversity in C. botulinum group III. 
This was studied by genotyping the strain collection with PFGE. Thirty-
seven strains were successfully genotyped and resulted in the pulsotypes 
demonstrated in Figure 7A. A subset of pulsotypes, which accounted for 27 of 
the strains, clustered closely together and differed by only one or two bands. 
Remaining pulsotypes were represented by a single or a few strains. Twelve C. 
botulinum group III genomes chosen to represent a diversity of both pulsotype 
and origin were sequenced (Figure 7). Pair-wise comparisons of the average 
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sequence similarity of these genomes and two older C. botulinum group III 
draft genomes retrieved from GenBank formed four lineages. Lineage I mainly 
consisted of strains with chimeric bont genes (type C/D and D/C) of both avian 
and bovine origin. Lineage I was designated two subgroups: Ia and Ib, on the 
basis of the very high sequence similarity between strains within these 
subgroups. Subgroup Ia corresponds to the largest cluster of related pulsotypes 
and Ib to the second largest pulsotype cluster (Figure 7). Lineage II comprised 
C. botulinum type C or D strains isolated from mammals. Lineage III and IV 
were diverged from lineage I and II and consisted of strains of avian or bovine 
origin encoding chimeric BoNT types. Care should be taken not to interpret 
two strains with very different PFGE banding patterns as genetically distantly 
related. For example, comparison of the PFGE banding patterns from strains of 
the two subgroups in lineage I revealed a very low similarity. Thus, genotyping 
of C. botulinum group III by PFGE identifies closely related strains but tells 
less about the overall genomic similarity between strains.   
 
Figure 7. An overview of genotyped and whole genome sequenced strains. A) Pulsed-field gel 
electrophoresis SmaI dendrogram of genotyped C. botulinum group III strains. Pulsotype clusters 
are framed B) Heat-plot illustrating pair-wise comparisons of the average sequence similarity of 
C. botulinum group III genomes (black), C. novyi genomes (red), and C. haemolyticum genomes 
(blue). Genome nr 1 is the completed genome described in paper III (BKT015925). Lineages (LI-
LIV) are framed. 
After the publication of paper IV, there was another genotyping study 
published using a flagellin detection assay targeting four different flagellin C 
gene types (fliC-I to fliC-IV) identified in strains of C. botulinum group III 
(Woudstra et al., 2015). This assay was applied on 204 samples naturally 
contaminated with C. botulinum group III strains originating from five 
different European countries. All bontC/D-positive samples contained the fliC-
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I type, which by far was the most commonly detected type (n=172). The 
reference sequence used for the fliC-I type was from BKT150925, which 
corresponds to one of the strains in the largest pulsotype cluster in Figure 7A 
and belongs to genomic lineage I (subgroup Ia). There is also an AFLP-
analysis previously published, where genotyping of 25 C. botulinum group III 
strains resulted in only four clusters (Hill et al., 2007). The C-Stockholm strain 
was used, which made it possible to identify one of the clusters as lineage II 
recognized in this thesis project. That cluster also contained strains of non-
chimeric types (C and D) and were mainly from mammals. Interestingly, 
another cluster (with only two strains) clustered closest with C. botulinum type 
G strains. 
Although more strains need to be analysed, this data suggests that C. 
botulinum group III can be divided up in only a few genomic groups containing 
strains of widely diverse origins. The overall pair-wise similarity of the most 
distantly related C. botulinum group III strains is lower than that seen in C. 
botulinum group I or II (data not shown), which thus can be considered to be 
less diverged than group III. The reason for this may be that the bont-phage 
present in C. botulinum group III has a broader host-spectrum than the bont-
carrying plasmids present in C. botulinum group I and II. It can also be 
speculated that the longer periods of C. botulinum group III strains propagating 
inside a host, which is the result of toxicoinfection, contribute to a higher rate 
of genome alterations than that seen in C. botulinum group I and II. 
5.3 The C. botulinum group III genome (paper III) 
One of the type C/D strains (08-BKT015925) from the largest pulsotype cluster 
(Figure 7) was chosen for whole genome sequencing and assembled into 
completion. The strain was isolated from a sample collected from a botulism 
outbreak in broiler chickens in Sweden 2008. Its genome consists of a circular 
chromosome and five circular plasmids, all with a low GC content of 26-28%. 
A schematic image of the BKT015925 genome is presented in figure 1 in paper 
III. Putative functions could be predicted for 66% of the chromosomal coding 
sequences (CDS) and for 38% of the total CDS in the five plasmids. The 
BKT015925 genome is smaller than the group I and II genomes, 3.2 Mbp 
compared to 3.6-4.4 Mbp. Furthermore, the number of plasmids in 
BKT015925 was found to be much higher than in the other two C. botulinum 
groups, where no strain has been characterised with more than two plasmids. 
The five plasmids in BKT015925 were named with designated prefixes of p1-
p5 ordered in decreased size. Only p2BKT015925 and p3BKT015925 were 
thought to be regular plasmids and the remaining three were considered to be 
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phages due to the presence of genes predicted to be associated with phage 
functions. However, these phage sequences are circular and also contain genes 
involved in plasmid replication and/or partitioning, thus they seem be 
prophages propagating like plasmids.  The presence of several smaller phages 
within one strain, besides the bont-phage (p1BKT015925), also correlates with 
early electron microscopy examinations of growth culture supernatants from C. 
botulinum group III strains (Hariharan and Mitchell, 1976). As these plasmid-
like phages are difficult to categorise, they will from here on be included in the 
general term plasmids. 
Another discovery in the C. botulinum group III genome was the abundance 
of insertion sequence (IS) elements. Five different IS elements (ISCbo1-5) 
were found in a high copy-number and in different positions in closely related 
strains, indicating that they are actively re-locating. All together, these mobile 
elements account for 3.4 % of the BKT015925 chromosome, and they are also 
located on the three largest plasmids. Eight additional re-locating IS elements, 
IsCbo7-13 (IS200/IS605 elements), were identified on the two largest 
plasmids, but they appear to be less active. A higher density of IS elements was 
found on the two regular plasmids (p2BKT015925 and p3BKT015925) than on 
the ones considered to be phages. Generally, transposons are considered to be a 
disadvantage to phage functionality. The IS elements were found to be inserted 
in non-coding regions on both replichores, except ISCbo2, which had a 
tendency to be incorporated into another mobile element, a tandem reverse 
transcriptase (ISCbo3). Some of these elements are related to previously 
identified IS elements in other bacteria species (Table 3), suggesting that 
horizontal gene transfer events have taken place between those species. 
ISCbo1, ISCbo4 and elements related to IS200/IS605 appear also in C. 
botulinum group I or II strains, although mainly in truncated form, in regions 
flanking the bont cluster. This implies that these elements have played some 
part in transfer of bont. However, only one IS element (ISCbo1) was located 
with close proximity to the bont cluster in one of the group III genomes. This 
was a complete element, as opposed to the same element found in a truncated 
form next to botR in C. botulinum group I OrfX clusters. The absence of traces 
of IS elements in the bont cluster in C. botulinum group III strains in 
combination with the smaller genome size could indicate a higher pressure to 




Table 3. Actively re-locating Insertion Sequence (IS) elements identified in the BKT015925 
genome and their relation to other IS elements.   
IS element IS family Positions in 
BKT015925 
Presence in C. 
botulinum group I or II 
Related element 
ISCbo1 IS6 28 Yes (truncated) ISCpe7 (C. perfringens) 
ISCbo2 IS21 14 Yes (truncated) IstA and IstB 
ISCbo3 - 8  Reverse transcriptase 
ISCbo4 IS256 8 Yes (truncated) ISCpe3 (C. perfringens) 
ISCbo5 IS1182 18 Yes (truncated) ISbma2 (Burkholderia 
mallei) 
ISCbo6-13 IS200/IS605 9 Yes OrfA and OrfB  
 
5.4 C. novyi sensu lato (paper I, III and IV)  
The definitions of the three species C. botulinum, C. novyi and C. 
haemolyticum are established on the basis of the toxin they produce: the BoNT 
of C. botulinum group III, the alpha-toxin of C. novyi type A and B, and the 
beta toxin of C. novyi type B and C. haemolyticum. However, they were 
already before the revolution of sequencing suggested to be closely related on 
the basis of DNA-DNA hybridization and biological characteristics. As a 
matter of fact, C. haemolyticum has since the late 1950s sometimes been 
referred to as C. novyi type D (Oakley and Warrack, 1959). The discovery that 
phages of C. novyi type A were able to infect C. botulinum group III strains, 
thus phenotypically converting them into C. novyi, further contributed to the 
assumption of a close relationship between these species. This was later 
established when 16S rRNA sequences were analysed from strains of the 
different species (Sasaki et al., 2001).  
Early in these studies, a C. botulinum type C strain (C-Stockholm) was 
concluded to be more closely related to C. haemolyticum and C. novyi type B 
than to the isolated avian type C/D strains, on the basis of 16S sequence 
comparisons. Later, the completed sequence of the chromosome from C. novyi 
strain NT was a valuable resource for defining the contig order when 
completing the genome sequence of the C. botulinum type C/D BKT015925 
strain. There were non-conserved regions scattered throughout the sequences, 
but all together a high conservation of gene synteny between the genomes. 
Also C. novyi and C. haemolyticum genomes were sequenced and compared to 
C. botulinum group III genomes. It turned out that the C. novyi and C. 
haemolyticum genomes could be organized into three of the same lineages as 
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the C. botulinum strains (Figure 7). Lineage I was the only one consisting 
solely of C. botulinum strains. The high average sequence similarity seen 
between genomes in the subgroups in lineage I suggests that they constitute 
two evolutionary younger branches than remaining lineages.  Lineage II 
comprised strains of all three species (C. botulinum type C and D, C. 
haemolyticum and C. novyi type B). C. novyi type A strains were organized 
into the relatively diverged branch composed of lineages III and IV.  
From these results it is clear that the current nomenclature formed on the 
basis of the toxin genes is not supported by a phylogenetic concept of a 
species. A new term, C. novyi sensu lato (meaning C. novyi in a broader sense), 
was proposed for a genospecies including C. botulinum group III, C. novyi and 
C. haemolyticum. Mainly responsible for the phylogenetic inconsistency are 
the phages harboring the species-defining toxin genes, which are able to move 
between different strains of different species. This will be discussed in the next 
two sections.  
5.5 The large mobile plasmidome of C. novyi sensu lato  (paper 
III and IV) 
Compared to the rather conserved chromosomes of C. novyi senu lato 
genomes, the remarkably large plasmidome was found highly variable within 
the lineages. All together 61 plasmids were identified and 23 of them were 
assembled into completed sequences. Many of these plasmids were considered 
to be phage-like plasmids. Apart from randomly distributed related genes, there 
was no apparent shared synteny between these plasmids and plasmids in other 
clostridia, including the ones from the other C. botulinum groups. 
Strains of C. botulinum group III, C. novyi type B and C. haemolyticum 
contained between three and five plasmids each, whereas strains of C. novyi 
type A only contained one (the C. novyi alpha-toxin phage). Genomes in 
lineage subgroup Ia contained the highest abundance of plasmids (four to five 
each). A PCR system detecting the different plasmids in lineage Ia was applied 
on non-sequenced strains belonging to the largest pulsotype cluster. It appeared 
that they all contained four or five plasmids each, always the regular plasmids 
corresponding to p2BKT015925 and p3BKT015925 in combination with at 
least two phage-like plasmids. 
The plasmids identified in C. novyi sensu lato were organized into 13 
plasmid groups (PG) on the basis of the relative amount of shared genetic 
material, in combination with the conservation of plasmid maintenance genes. 
An image of the genetic relationship between the plasmids and their 
organization into plasmid groups is presented in figure 2 in paper IV. Some of 
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the plasmid groups contained a substantial variety of plasmid origin; from 
strains belonging to different genomic lineages and from strains of different 
species. For example, the bont-phage (PG1) was found in all lineages (with or 
without bont). The plasmid sequences in most of the plasmid groups mimicked 
the phylogeny of the whole genome sequences, indicating an infrequent or 
temporary horizontal movement between strains of these species. The 
exceptions were the C. novyi alpha-toxin phage (PG9 and PG10), which is 
described further below, and a bont-phage (PG1) derived from lineage III but 
closest resembled bont-phages from lineage I. The other bont-phages from 
lineage III and the only one in lineage IV had already been lost in the 
population upon cultivation. The scarcity of PG1 plasmids in those two 
lineages suggests that the lysogenic relationship is only temporary in these 
strains. It is possible that an infection by these phages into a new host does not 
result in a stable lysogenic relationship, perhaps due to incompatibility with 
existing plasmids. 
The second most dynamic plasmid group was PG10, with plasmids from 
lineage II, III and IV. The PG10 plasmids from lineage IV contained the gene 
coding for the C. novyi alpha-toxin, whereas plasmids from lineage II and III 
did not. This plasmid group was genetically related to PG8, PG9 and to a less 
extent also to PG11, all consisting of phage-like plasmids with a modular 
structure. Alignment of these plasmids showed a high similarity in some 
clusters of functionally related genes between plasmids of the different groups, 
in contrast to the very low similarity surrounding these clusters. This shows a 
tendency of exchanging modules of functionally related genes with each other, 
which has resulted in a very mosaic group of phage-like plasmids. 
The plasmid groups that consisted of regular plasmids contained no outliers 
with discordant phylogeny compared to its corresponding genomes, indicating 
a stable genomic relationship and a low transfer activity. Only two putative 
conjugation genes were found on these plasmids, but additional genes 
associated with conjugation can have been missed since many of the plasmid 
genes lacked predicted functions. A plasmid of a lineage Ia strain (08-
BKT015925) was tagged using the ClosTron mutagenesis system (Heap et al., 
2007). The modified strain was co-incubated with a C. novyi type A strain (07-
BKT029909), but no conjugants were detected. It is still possible that 
conjugation can occur in the environment at certain favorable conditions, but 
the data collected in this thesis project shows no signs of plasmid transfer 
between lineages, except when it is governed by phages. In general, the phage-
like plasmids found in C. novyi sensu lato seem to be more unstable than the 
regular plasmids as they were easier to remove from a strain by heat or by 
chemical treatment.  
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5.6 Pathogenicity in C. novyi sensu lato (paper III and IV) 
The three species in C. novyi sensu lato are known for their ability to cause 
different diseases: botulism, gas gangrene (C. novyi), black disease (C. novyi) 
and bacillary hemoglobinuria (C. haemolyticum), respectively. Both black 
disease and bacillary hemoglobinuria, which affect herbivores, are caused by 
germination of spores in the liver upon liver damage (usually by liver flukes), 
which reduces oxygen levels. As already mentioned, these diseases are caused 
by different toxins. It appeared upon analysis of sequenced C. novyi sensu lato 
genomes that besides the transfer of toxin-encoding phages, toxin genes also 
show an independent variability of location.  
The genes encoding BoNT and the C3 toxin were found on all PG1 
plasmids, except the one derived from C. haemolyticum (Figure 8). The 
presence of a PG1 phage without these toxin genes supports the idea that they 
at some point have been inserted or deleted from PG1. The fact that both toxin 
genes are missing raises the question if their presence is connected. The mobile 
element harboring the C3 gene was also missing in a phage with a mutated 
bont gene, further supporting this idea (Hauser et al., 1993). The bont cluster 
sequences were more conserved (all were ha clusters) and their locations more 
consistent in C. botulinum group III than in C. botulinum group I or II, 
indicating less mobility of the bont cluster or that it has been more recently 
introduced into C. botulinum group III (Figure 8). The only big genetic 
alterations that seem to have happened to the bont cluster in group III strains 
are the ones responsible for the chimeric sequences bontC/D and bontD/C. 
Sequence alignment of chimeric sequences against non-chimeric sequences 
revealed different recombination sites in the two chimeric sequence types. The 
estimated recombination sites are illustrated in figure 4 in paper IV. 
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(bont) and the c3 
toxin gene, except 
in p1Ch9693 from 
C. haemolyticum. 
The gene encoding the C. novyi alpha-toxin was found in all C. novyi strains 
but on different plasmids (PG9 and PG10). The phospholipase C gene, which 
constitutes the beta toxin in C. novyi type B and C. haemolyticum, was 
chromosomally located, except in lineage Ia strains where it was found on a 
plasmid (PG3). The genes encoding the C2 toxin components were only found 
in C. botulinum group III strains of lineage Ia and II, but were localized on 
different plasmids (PG3 or PG4). 
Besides these more known toxins, other putative toxin candidates are also 
produced by strains of C. novyi sensu lato (Figure 9). Besides the 
phospholipase C gene, only one other putative toxin gene was found on the 
chromosome and it was closest related to tetanolysin, which is believed to 
contribute to the pathogenesis in an infection by C. tetani. The high degree of 
conservation and its existence in all genomes so far analysed of C. novyi sensu 
lato, indicate an important function and also one more evolutionary link to C. 
tetani. The gene coding for an extracellular cysteine endopeptidase of high 
similarity to clostripain produced by C. histolyticum (>75% amino acid 
identity), was found in all the lineages, but also in C. botulinum group I and II 
strains. This enzyme has been proposed to be the endogenous protease 
responsible for cleaving the neurotoxin into a light and heavy chain, which is 
required for its toxicity (Sebaihia et al., 2007). Interestingly, the clostripain 
gene was located on the chromosome in C. botulinum group I and II strains and 
in C. novyi sensu lato lineage III and IV strains, but on PG2 plasmids in 
lineage I and II strains, adjacent to another putative toxin gene encoding an 
aerolysin. The aerolysin gene was found in all lineage I and II strains and 
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shared 53-64% amino acid identities (highest score in lineage I strains) with 
the alpha-toxin of C. septicum. Lastly, two tandem located putative epsilon 
type B toxin genes were identified on different plasmids of C. botulinum 
strains (PG7 and PG4). 
All the identified putative toxin genes, except tetanolysin, had a variable 
presence or were found on different replichores in different strains (Figure 9).  
 
Figure 9. The location of toxin genes in C. novyi sensu lato. Toxin genes are illustrated with red 
boxes. Striped boxes illustrate a varying presence of the toxin gene within the plasmid group. 
Botulinum neurotoxin gene (bont) and Phospholipase C gene (plpC).  
Transposons were found adjacent to several of the toxin genes, to bont 
(ISCbo1), the C. novyi alpha-toxin gene (ISCbo10 and a site specific 
recombinase), and the epsilon B toxin gene (a site-specific recombinase), 
suggesting involvement in the transfer. The re-location of toxin genes, by 
phage movements, by recombination, or by transposons, is likely to change the 
pathogenicity of the strain and complicates the definition of the species. In this 
project, one C. novyi type A strain was isolated from a chicken caecum sample 
collected during a botulism outbreak. This shows how entwined these 
organisms are, and that there are opportunities for the phages to move between 
strains of different lineages. When a new strain is isolated it will be identified 
upon the presence of the toxin-encoding phage, even if it was only a temporary 
phage infection. This is reflected by outliers revealed in phylogeny studies, for 
example one C. novyi strain that clustered with C. sporogenes (Stackebrandt et 
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al., 1999), and C. botulinum group III strains that clustered with C. botulinum 
type G strains (Hill et al., 2007). All are probably consequences of the dynamic 
toxin-encoding phages. 
5.7 The successful lineage I 
The subgroup Ia of lineage I was overrepresented among strains isolated during 
this thesis project, and among the vast number of European samples analysed 
by Woudstra et al. (Woudstra et al., 2015). Lineage I seems to be the natural 
host for phages carrying bontC/D and bontD/C. As previously discussed, the 
increased toxicity of chimeric bont genes may have led to a raised number of 
botulism outbreaks and thereby the isolation of an increased number of lineage 
I strains. However, this is probably not the complete answer as there are more 
strains genotyped corresponding to subgroup Ia than of Ib. Strains in subgroup 
Ia were the only ones containing all the toxin genes described above, except 
the C. novyi alpha-toxin. Perhaps a combination of the functions of all putative 
toxin genes contribute to more virulent strains. The highest density of plasmids 
and IS elements was also found in subgroup Ia genomes, which might have 
contributed to the evolvement of a better adapted genome, perhaps better 




When the studies for this thesis started no culturing of clinical samples was 
applied at SVA. During 2007 and 2008 when the number of avian botulism 
outbreaks increased by ten-folds, we still did not know much about the causing 
strains, only that they were C. botulinum type C/D. As a result of this thesis 
project, culturing, molecular identification and genotyping methods for C. 
botulinum group III are now established at SVA. Thanks to these improved and 
implemented diagnostic methods it was possible to obtain well characterised 
strains, which were used to study both the organization and diversity of the C. 
botulinum group III genomes. 
The C. botulinum group III genome is organized into a conserved 
chromosome with little excessive material, which instead is kept on highly 
plastic and dynamic plasmids (including phage-like plasmids). This is probably 
an efficient solution allowing for rapid adaptation when changing habitat, for 
example from soil to animal intestines. The C. botulinum group III strains 
analysed so far by different genotyping techniques can be organized into only a 
few genomic lineages, which all contain strains of widely diverse origins. 
These lineages also comprise C. novyi and C. haemolyticum genomes, which 
shows the close genomic relationship between these three species that are 
collectively described as C. novyi sensu lato. The mix of species in the lineages 
is the result of the dynamic nature of phages carrying the toxin genes upon 
which these species are identified. Actually, most of the putative toxin genes 
identified in C. botulinum group III are located on plasmids and are also as the 
many IS elements, actively or sporadically re-locating. Some of the putative 
toxin genes and IS elements are related to genes found in other bacteria species 
(mainly clostridia species), which show that C. botulinum group III genomes 
are to some extent influenced by its environment by horizontal gene transfer.  
One C. novyi sensu lato genomic lineage seems to have developed as C. 
botulinum specific and consists of strains most commonly causing avian 
botulism, and possibly animal botulism in general, in Europe today. The 
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majority of the strains in this lineage encode chimeric BoNTs of type C/D or 
D/C. The spread of these possibly more virulent strains may have contributed 
to the elevated number of botulism outbreaks being reported during the last 
decade.  
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7 Perspectives for the future 
Botulism is a devastating and costly disease for the animal husbandry and 
deserves more attention in the veterinary and scientific field. There are not 
enough efficient countermeasures or official guidelines developed for handling 
animal botulism outbreaks. Further, if animal botulism was a notifiable disease 
in all countries, the number of officially reported cases would increase and give 
a more accurate picture of the prevalence of the disease. It would also add to an 
awareness of fluctuations in outbreaks and to epidemiological conclusions.  
 
When writing this thesis some future research needs became clear: 
 
 In this thesis project, a number of putative new virulence factors were 
identified. These need to be further characterised in terms of expression and 
functionality.  
 
 Little is still known of the basic biology of the bont-phage. What stabilizes 
the lysogenic relationship and what triggers the lytic cycle are two 
questions that are still to be answered. Further, the host-bacteria 
relationship in toxicoinfection is hardly explored at all. It would be valuable 
for the animal husbandry to know if there are certain triggers, such as a feed 
component or the composition of intestinal flora, for toxicoinfection to be 
established.  
 
 What we need now in terms of diagnostics are fingerprinting profiles that 
can be exchanged by laboratories easier than the first generation genotyping 
techniques such as PFGE and RAPD. As a result of this thesis there are now 
a number of different C. botulinum group III genome sequences easily 
accessible to the scientific community. These can be used to define for 
example MLST loci with a power to discriminate also between closely 
related strains. Genome sequencing will in the future likely be commonly 
applied by diagnostic laboratories, but in the meantime an MLST method 
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can be applied both by the laboratories with access to whole genome 





8 Populärvetenskaplig sammanfattning 
Bakgrund 
Jordbakterien och sporbildaren Clostridium botulinum bildar botulinumtoxin 
(BoNT), ett av världens farligaste gifter. BoNT är ett nervgift som orsakar 
förlamningssjukdomen botulism hos både människor och djur. Vanligast är 
botulism hos djur, som ibland drabbas av stora utbrott med hög dödlighet. I 
Sverige är det vanligast med botulism hos fjäderfä och framför allt 
slaktkycklingar har drabbats hårt det senaste decenniet. Det har även 
rapporterats botulismutbrott bland sjöfåglar i Sverige. Botulism hos fåglar, s.k. 
aviär botulism, förekommer i hela världen, och stora utbrott har rapporterats de 
senaste åren från bl.a. Spanien och Sydkorea. Andra djur som drabbas relativt 
ofta av botulism är nötkreatur, häst, får och mink. 
Botulism uppstår oftast av att man får i sig förbildat toxin, vanligtvis genom 
mat eller foder, s.k. klassisk botulism. För att C. botulinum ska kunna växa och 
bilda gift krävs en totalt syrefri miljö, såsom i konservburkar eller ensilage. I 
sår kan också en delvis syrefri miljö uppstå där gift kan bildas och orsaka 
sårbotulism. I mer sällsynta fall kan bakterien växa till sig i tarmen 
(toxikoinfektion) hos vuxna människor och djur, men denna form av botulism 
är desto vanligare hos unga djur, spädbarn (spädbarnsbotulism) och fåglar.  
C. botulinum är en väldigt divergerad bakterieart som brukar delas in i fyra 
grupper (grupp I-IV) baserat på genetiskt innehåll och fysiologiska egenskaper 
så som t.ex. tillväxttemperatur och sporernas resistens mot värme. Gemensamt 
för dessa är att de alla har förmågan att bilda BoNT. Det har visat sig att 
stammar av de fyra grupperna egentligen är närmare besläktade med andra 
bakteriearter än med varandra. T.ex. är C. botulinum grupp III nära besläktad 
med Clostridium novyi och Clostridium haemolyticum, två arter som orsakar 
helt andra sjukdomar än botulism.   
Hittills har sju olika typer av BoNT konfirmerats (typ A-G) med hjälp av 
olika antikroppars förmåga att neutralisera toxinets verkan. BoNT typ A, B, E 
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och F orsakar majoriteten av botulismfallen hos människor. Typ G har än så 
länge endast vid ett tillfälle påvisats i samband med human botulism. Botulism 
hos djur orsakas vanligtvis av BoNT typ C och D, även om typ B också är 
förknippat med botulism hos nötkreatur och häst och typ E med fisk och 
sjöfåglar. Två hybrider av BoNT typ C och D (typ C/D och D/C) upptäcktes på 
90-talet och orsakar idag många av botulismutbrotten hos djur. Det har visats 
att BoNT typ C/D är mer giftig för fåglar än BoNT typ C eller D, och att BoNT 
typ D/C troligen är mer giftig för nötkreatur än typ C eller D. BoNT typ C, D, 
C/D och D/C bildas av bakterier tillhörande C. botulinum grupp III. Dessa 
bakterier bär genen som kodar för toxinet på en bakteriofag (bakterievirus) som 
ligger vilande i bakterien. Ibland lämnar fagen bakteriecellen och då tappar 
cellen förmågan att bilda BoNT.  
C. botulinum bakterier av grupp III är speciellt svåra att odla fram i 
renkultur. Dels för att de är mycket syrekänsliga, men framför allt för att de 
växer sämre än många andra bakterier som också finns i miljöprover och 
prover från djur. Ett annat problem som ibland uppstår gäller korrekt 
identifiering av bakterien. Vanligen identifieras den genom att man detekterar 
BoNT eller genen som kodar för BoNT. Om fagen som bär genen som kodar 
för BoNT har lämnat bakterierna blir det svårt att identifiera stammen som C. 
botulinum. Dessa problem ligger till grund för att man inte vet så mycket om 
de stammar som orsakar botulism hos djur.  
Studier och Resultat 
I studierna som ledde fram till den här avhandlingen utvecklades och 
förfinades metoder för att isolera stammar av C. botulinum grupp III för att 
kunna studera deras genetiska uppsättning och jämföra dem med varandra. 
Majoriteten av stammarna som isolerades var från prover som samlats in under 
svenska utbrott av aviär botulism. Det isolerades också stammar från 
fågelprover insamlade i Norge, Danmark och Spanien. Några stammar från 
nötkreatur från Italien och Nederländerna och en stam från gris från Sydkorea 
ingick också i stamkollektionen.  
Det totala DNA-innehållet hos dessa stammar jämfördes med hjälp av 
pulsfälts-gel elektrofores (PFGE). I PFGE klyvs DNA i olika långa fragment 
med hjälp av restriktionsenzym som klyver specifikt vid vissa kombinationer 
av baserna A, T, G och C. De olika långa DNA fragmenten separeras sedan i 
storleksordning i en gel genom att applicera ett elektriskt fält som konstant 
byter riktning. På så sätt får man fram ett mönster av band i olika storlekar som 
kan jämföras med mönster från andra stammar av samma art. Detta visar vilka 
stammar som är närbesläktade med varandra. Det visade sig att majoriteten av 
de stammar som orsakat aviär botulism var närbesläktade, oavsett geografisk 
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härkomst. Dessa stammar var också närbesläktade med en stam isolerad från 
nötkreatur.  
Tolv stammar valdes ut att representera olika pulsfältsmönster, samt 
härkomst från olika geografiska platser och olika djurslag. Dessa 
helgenomsekvenserades, dvs. det totala DNA-innehållet i form av korta 
överlappande DNA-sekvenser lästes av. Denna metod har en högre upplösning 
än PFGE, eftersom man istället för ett DNA-mönster har tillgång till den totala 
DNA-sekvensen (genomet). När DNA-innehållet jämfördes kunde stammarna 
delas upp i fyra olika genetiska undergrupperingar. DNA-sekvenserna i ett av 
dessa genom, från en stam isolerad från ett svenskt botulismutbrott på 
slaktkyckling 2008, pusslades ihop till ett komplett genom. Detta studerades 
närmare och visade sig vara mindre än genom av C. botulinum grupp I och II. 
Det mest intressanta med genomet i övrigt var att det innehöll ovanligt många 
(fem stycken) mindre självständiga DNA-enheter (plasmider). Tre av dessa 
plasmider visade sig vara vilande bakterievirus som uppför sig som plasmider 
(bl.a. den fag som bär genen för BoNT). Vidare innehöll genomet flera 
potentiella toxingener samt många återkommande (repetetiva) gener och bägge 
dessa gentyper påträffades på olika ställen vid jämförelse med genom från 
andra stammar av C. botulinum grupp III. Flera av dem liknar motsvarande 
gener i andra bakteriearter, vilket indikerar att dessa har överförts mellan 
bakterier. Ibland tar repetetiva gener med sig omkringliggande DNA-sekvenser 
när de flyttar på sig, t.ex. närliggande toxingener, vilket troligen har hänt vid 
flera tillfällen i C. botulinum. Detta kan påverka bakteriens förmåga att orsaka 
sjukdom.  
Då C. botulinum grupp III-genomen jämfördes med genom av C. novyi och 
C. haemolyticum visade det sig att de senare var så pass lika några av C. 
botulinum-stammarna att de kunde delas in i samma undergrupperingar. Dessa 
arter är så närbesläktade att de genetiskt borde anses vara samma art. 
Fenotypiskt finns ju dock vissa skillnader i och med att de har förmågan att 
bilda olika toxin och därmed orsaka olika sjukdomar. Den största anledningen 
till att stammar av dessa arter är så genetiskt ihopblandade i de olika 
undergrupperingarna är att de fager som bär på toxingener (vilka används för 
identifikation av både C. botulinum grupp III och C. novyi) ibland flyttar sig 
mellan dessa stammar.  
Slutsatser 
C. botulinum är en divergerad art på grund av att genen som kodar för BoNT 
har överförts mellan olika mindre närbesläktade stammar. Genen som kodar för 
BoNT typ C, D, C/D och D/C hos stammar av C. botulinum grupp III bärs av 
en fag som också kan infektera stammar av C. novyi och C. haemolyticum. 
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Detta gör att dessa istället identifieras som C. botulinum. I och med att dessa 
tre arter är så närbesläktade vore det mer korrekt att dela in dem i samma art. 
Av den anledningen har vi föreslagit den kollektiva termen C. novyi sensu lato. 
Dessa studier tyder på att stammar av C. botulinum grupp III kan delas in i 
endast ett fåtal genetiska undergrupper. En av dem består av bara C. botulinum 
stammar och den motsvarar majoriteten av de stammar som isolerats från aviär 
botulism (oavsett geografiskt usprung), samt majoriteten av de stammar som 
producerar hybridtyperna av BoNT (C/D och D/C). Detta tyder på att dessa 
möjligen mer virulenta stammar sprider sig över Europa och är ansvariga för 
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